Markers of axonal injury in post mortem human brain. 1994

F E Sherriff, and L R Bridges, and S M Gentleman, and S Sivaloganathan, and S Wilson
University of Oxford, Department of Clinical Neurology (Neuropathology), Radcliffe Infirmary, Oxford, UK.

beta-Amyloid precursor protein (beta APP) can be detected immunocytochemically at sites of axonal injury in the brain, and has recently been found to be a useful marker for injured axons in patients who survived for only 3 h after head trauma. It is transported by fast axonal transport and is thought to accumulate in detectable levels where the cytoskeleton breaks down. If this theory is correct, other substances should accumulate here in the same way, so we have used antibodies to other neuronal proteins to compare their efficacy as markers of axonal injury. SNAP-25, chromogranin A and cathepsin D also marked injured axons at all survival times studied (2.5 h-2 weeks), although they were not as sensitive or specific as beta APP. Immunolabelling for the 68-kDa neurofilament subunit (NF68) was present in most uninjured axons, and allowed axonal swellings to be seen in some cases. Synaptophysin, GAP-43, ubiquitin or tau did not label any normal or injured axons in this study. We, therefore, suggest that beta APP should be the immunocytochemical marker of choice for the detection of injured axons. This study also showed that microwave antigen retrieval significantly enhances the immunoreactivity of SNAP-25, chromogranin A, synaptophysin, GAP-43, ubiquitin and tau, in addition to that of beta APP, in formalin-fixed, paraffin-embedded tissue, and reveals NF68 antigenicity where it was not previously detectable.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D007223 Infant A child between 1 and 23 months of age. Infants
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009419 Nerve Tissue Proteins Proteins, Nerve Tissue,Tissue Proteins, Nerve
D011328 Prions Small proteinaceous infectious particles which resist inactivation by procedures that modify NUCLEIC ACIDS and contain an abnormal isoform of a cellular protein which is a major and necessary component. The abnormal (scrapie) isoform is PrPSc (PRPSC PROTEINS) and the cellular isoform PrPC (PRPC PROTEINS). The primary amino acid sequence of the two isoforms is identical. Human diseases caused by prions include CREUTZFELDT-JAKOB SYNDROME; GERSTMANN-STRAUSSLER SYNDROME; and INSOMNIA, FATAL FAMILIAL. Mink Encephalopathy Virus,Prion,Encephalopathy Virus, Mink
D011498 Protein Precursors Precursors, Protein
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D001930 Brain Injuries Acute and chronic (see also BRAIN INJURIES, CHRONIC) injuries to the brain, including the cerebral hemispheres, CEREBELLUM, and BRAIN STEM. Clinical manifestations depend on the nature of injury. Diffuse trauma to the brain is frequently associated with DIFFUSE AXONAL INJURY or COMA, POST-TRAUMATIC. Localized injuries may be associated with NEUROBEHAVIORAL MANIFESTATIONS; HEMIPARESIS, or other focal neurologic deficits. Brain Lacerations,Acute Brain Injuries,Brain Injuries, Acute,Brain Injuries, Focal,Focal Brain Injuries,Injuries, Acute Brain,Injuries, Brain,Acute Brain Injury,Brain Injury,Brain Injury, Acute,Brain Injury, Focal,Brain Laceration,Focal Brain Injury,Injuries, Focal Brain,Injury, Acute Brain,Injury, Brain,Injury, Focal Brain,Laceration, Brain,Lacerations, Brain
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000072002 Prion Proteins Membrane glycosylphosphatidylinositol-anchored glycoproteins that may aggregate into rod-like structures. The prion protein (PRNP) gene is characterized by five TANDEM REPEAT SEQUENCES that encode a highly unstable protein region of five octapeptide repeats. Mutations in the repeat region and elsewhere in this gene are associated with CREUTZFELDT-JAKOB DISEASE; FATAL FAMILIAL INSOMNIA; GERSTMANN-STRAUSSLER DISEASE; Huntington disease-like 1, and KURU. PrP Proteins,AltPrP,Alternative Prion Protein,CD230 Antigen,Creutzfeldt-Jakob Disease Protein,Fatal Familial Insomnia Protein,Major Prion Protein,Prion Protein,Antigen, CD230,Creutzfeldt Jakob Disease Protein,Prion Protein, Alternative,Prion Protein, Major

Related Publications

F E Sherriff, and L R Bridges, and S M Gentleman, and S Sivaloganathan, and S Wilson
January 1986, Progress in brain research,
F E Sherriff, and L R Bridges, and S M Gentleman, and S Sivaloganathan, and S Wilson
January 2018, Folia neuropathologica,
F E Sherriff, and L R Bridges, and S M Gentleman, and S Sivaloganathan, and S Wilson
January 2009, Journal of neuroscience methods,
F E Sherriff, and L R Bridges, and S M Gentleman, and S Sivaloganathan, and S Wilson
January 1992, British journal of pharmacology,
F E Sherriff, and L R Bridges, and S M Gentleman, and S Sivaloganathan, and S Wilson
January 1993, Neurophysiologie clinique = Clinical neurophysiology,
F E Sherriff, and L R Bridges, and S M Gentleman, and S Sivaloganathan, and S Wilson
December 1973, Brain research,
F E Sherriff, and L R Bridges, and S M Gentleman, and S Sivaloganathan, and S Wilson
March 2010, Journal of neurotrauma,
F E Sherriff, and L R Bridges, and S M Gentleman, and S Sivaloganathan, and S Wilson
August 1982, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society,
F E Sherriff, and L R Bridges, and S M Gentleman, and S Sivaloganathan, and S Wilson
October 1984, Journal of the neurological sciences,
F E Sherriff, and L R Bridges, and S M Gentleman, and S Sivaloganathan, and S Wilson
January 1981, Advances in biochemical psychopharmacology,
Copied contents to your clipboard!